Efficacy of Cerebrolysin® in Alzheimer’s disease

Background. Alzheimer’s disease (AD) accounts for about half of all cases of senile dementia. Its prevelance increases steeply with age, from less than 1% at 60 to 15% in the 9th decade. The disease causes great suffering to patients and their families, and huge costs to society. Four million patients suffer from AD in the USA alone.